Venus Concept Inc. (VERO): Price and Financial Metrics

Venus Concept Inc. (VERO)

Today's Latest Price: $2.47 USD

0.14 (6.01%)

Updated Nov 23 6:55pm

Add VERO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

VERO Stock Summary

  • In terms of twelve month growth in earnings before interest and taxes, Venus Concept Inc is reporting a growth rate of 154.09%; that's higher than 91.56% of US stocks.
  • Revenue growth over the past 12 months for Venus Concept Inc comes in at 725.36%, a number that bests 98.9% of the US stocks we're tracking.
  • Venus Concept Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -86.42%, greater than the shareholder yield of just 4.32% of stocks in our set.
  • Stocks that are quantitatively similar to VERO, based on their financial statements, market capitalization, and price volatility, are FARM, PFMT, SUNW, MNTX, and NPO.
  • Visit VERO's SEC page to see the company's official filings. To visit the company's web site, go to

VERO Stock Price Chart Interactive Chart >

Price chart for VERO

VERO Price/Volume Stats

Current price $2.47 52-week high $9.00
Prev. close $2.33 52-week low $2.01
Day low $2.30 Volume 128,200
Day high $2.50 Avg. volume 119,263
50-day MA $2.32 Dividend yield N/A
200-day MA $3.53 Market Cap 101.60M

Venus Concept Inc. (VERO) Company Bio

Venus Concept Inc. (formerly Restoration Robotics, Inc.), a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. It offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. The company was founded in 2002 and is based in San Jose, California.

VERO Latest News Stream

Event/Time News Detail
Loading, please wait...

VERO Latest Social Stream

Loading social stream, please wait...

View Full VERO Social Stream

Latest VERO News From Around the Web

Below are the latest news stories about Venus Concept Inc that investors may wish to consider to help them evaluate VERO as an investment opportunity.

Non-Invasive Fat Reduction Market is Expected to Rise at A Robust CAGR15.8% by 2026 Involving Top Players | BTL, Cutera, ZELTIQ Aesthetics, Solta Medical, Venus Concept, Alma Lasers+

The Non-Invasive Fat Reduction market report by Reports and Data provides an extensive overview of the vital elements of the Non-Invasive Fat Reduction market and factors such as the drivers, restraints, latest trends, supervisory scenario, competitive landscape, technological advancements, and

OpenPR | September 28, 2020

Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript

Venus Concept, Inc. (VERO) Q2 2020 Earnings Conference Call August 13, 2020, 17:00 ET Company Participants Domenic Serafino - CEO & Director Domenic Della Penna - CFO Chad Zaring - Chief Commercial Officer Conference Call Participants Suraj Kalia - Oppenheimer Anthony Vendetti - Maxim Group Marie Thibault - BTIG Presentation...

SA Transcripts on Seeking Alpha | August 14, 2020

Venus Concept EPS misses by $0.02, beats on revenue

Venus Concept (VERO): Q2 GAAP EPS of -$0.39 misses by $0.02.Revenue of $17M (-38.8% Y/Y) beats by $0.46M.Press Release...

Seeking Alpha | August 13, 2020

Venus Concept Reports Preliminary Revenue Results for Second Quarter 2020

TORONTO, July 16, 2020 -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary revenue.

Yahoo | July 16, 2020

Venus Concept Inc. Announces FDA 510(k) Clearance for Venus Viva MD

Venus Concept Inc. (“Venus Concept” or the “Company”) (VERO), a global medical aesthetic technology leader, today announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD. Venus Viva MD is a non-invasive device intended to be used by aesthetic-related physicians or dermatologists. It expands the Company’s skin rejuvenation offerings beyond the Venus Viva™ and Venus Versa™ which were introduced to the medical aesthetics market in 2015 and 2016, respectively.

Yahoo | July 1, 2020

Read More 'VERO' Stories Here

VERO Price Returns

1-mo -2.76%
3-mo -19.81%
6-mo -19.02%
1-year -19.94%
3-year -99.82%
5-year N/A
YTD -47.45%
2019 -95.25%
2018 -90.43%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8215 seconds.